Overview
Chronic mucocutaneous candidiasis (CMC) is a persistent fungal infection primarily affecting mucous membranes and skin, often linked to underlying immune deficiencies, particularly involving T-lymphocyte dysfunction 2.Diagnosis
Clinical Presentation: Persistent or recurrent candidal infections of skin, nails, and mucous membranes 2.
Immunological Assessment: Evaluate T-cell function and lymphokine production in response to Candida antigens 2.
Imaging: Consider MRI for vessel wall assessment in cases with suspected complications like brain aneurysms 1.Management
First-Line Treatments:
- Antifungal Agents: Ketoconazole (dose specifics not detailed here) 3.
- Alternative Agents: Clotrimazole, amphotericin B 2.
Adjunctive Therapies:
- Immune Correction: Transfer factor to address underlying immune defects 2.
- Monitoring: Regular follow-up to assess response and manage adverse effects like hypertension or drug-induced hepatitis 3.Special Populations
Comorbidities: Patients with concurrent dermatophytoses or endocrine abnormalities may require tailored management approaches 3.
Treatment Response Variability: Nail infections may have more variable responses compared to mucosal and cutaneous lesions 3.Key Recommendations
Initiate antifungal therapy with ketoconazole for effective treatment of CMC, considering alternative antifungals if resistance is suspected (Evidence: Moderate 3).
Assess and address underlying immune deficiencies, potentially using transfer factor, to enhance treatment outcomes (Evidence: Weak 2).
Monitor for and manage adverse effects such as hypertension and hepatotoxicity during prolonged antifungal therapy (Evidence: Moderate 3).References
1 Lopes AJM, Caldas JG, Ferraz F, Teixeira MJ, Figueiredo EG. Vessel wall MRI revealing inflammation on brain aneurysm associated to chronic mucocutaneous candidiasis. British journal of neurosurgery 2019. link
2 Kirkpatrick CH. Host factors in defense against fungal infections. The American journal of medicine 1984. link
3 Horsburgh CR, Kirkpatrick CH. Long-term therapy of chronic mucocutaneous candidiasis with ketoconazole: experience with twenty-one patients. The American journal of medicine 1983. link90511-9)